Dendrite Forms Services Partnership with SAP America.

Business Editors/Health/Medical Writers/High-Tech Writers

MORRISTOWN, N.J.--(BUSINESS WIRE)--April 13, 2004

Further Reflects Dendrite's Commitment to Provide

Pharmaceutical Clients With Flexibility in Solution

Selection, Deployment, and Service

Dendrite International, Inc. (NASDAQ: DRTE) today announced a services partnership with SAP America Inc. that will provide end-to-end support services to U.S. pharmaceutical companies deploying the SAP(R) for Pharmaceuticals solution.

Pharmaceutical companies that select this joint offering will be able to leverage SAP's industry solution, matched with Dendrite's specific pharmaceutical services, providing them with a unique competitive advantage. Committed to helping companies maximize their technology investments, Dendrite will add the SAP for Pharmaceuticals solution to its growing portfolio of supported applications.

As part of the agreement, Dendrite will become an SAP Services Partner and provide deployment and training services, help desk and data center services, as well as hardware and asset management support to companies using the SAP portfolio of industry-specific business solutions. Dendrite will also offer direct-to-physician interactive marketing services--including sample management and fulfillment services--to SAP customers.

Dendrite will continue to develop, sell, and service its own leading sales effectiveness solutions. These solutions include the company's flagship WebForce(TM) suite, which will see a major new release in the fall.

"With this new agreement, Dendrite reinforces its position as the preeminent supplier of pharmaceutical support services, and showcases its commitment to provide customers with expertise and flexibility regardless of whether they choose CRM solutions developed internally, by Dendrite, or by other enterprise software providers," said Dendrite President and Chief Operating Officer Paul Zaffaroni. "We believe the partnership with SAP presents a strong combination of software and services for companies seeking additional CRM alternatives."

About Dendrite

Dendrite develops and delivers solutions that increase the productivity of sales, marketing, and clinical processes for pharmaceutical and other life science clients. For more information, visit www.dendrite.com.

Note: Dendrite is a registered trademark of Dendrite International, Inc.

SAP and all other SAP product and service names mentioned herein are trademarks or registered trademarks of SAP AG in Germany and in several other countries around the world.

The foregoing contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The statements may be identified by such forward-looking terminology as "expect," "believe," "may," "will," "intend," "plan," and similar statements or variations. All "outlook" information constitutes forward-looking statements. Such forward-looking statements are based on our current expectations, estimates, assumptions and projections and involve certain significant risks and uncertainties, including those which may result from our dependence on the pharmaceutical industry; dependence on major customers; economic pressures and legislative and regulatory impact on our customers; fluctuations in quarterly revenues due to lengthy sales and implementation cycles for our products; our fixed expenses in relation to fluctuating revenues; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; international operations; acquisitions; our ability to attract and retain key personnel; the protection of our proprietary technology; our ability to compete in the Internet-related products and services market; the continued demand for Internet-related products and services; the ability of our third party vendors to respond to technological change; our ability to maintain our relationships with third-party vendors; results from strategic relationships; risks associated with events that may affect the world economy, including terrorism, military action in the Middle East or threat of other hostilities in the Middle East, Asia and other geographical regions; catastrophic events which could negatively affect our information technology infrastructure; difficulties disposing of certain of our facilities; and unexpected changes in accounting regulations, standards or interpretations. Other important factors that should be considered are included in the Company's 10-K, 10-Qs, and other reports filed with the SEC. Actual results may differ materially. The Company assumes no obligation for updating any such forward-looking statements to reflect actual results, changes in assumptions or other changes affecting such forward-looking statements.